Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer. Fasano GA, Bayard S, Chen Y, Varella L, et al. Breast Cancer Res Treat 2022 Jan 13. pii: 10.1007/s10549-021-06481.

Read + Share

Amedeo Smart

Independent Medical Education

Fasano GA, Bayard S, Chen Y, Varella L, et al. Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer. Breast Cancer Res Treat 2022 Jan 13. pii: 10.1007/s10549-021-06481.
PMID: 35022867